Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases
Monday, May 16, 2022Inmagene Biopharmaceuticals announces that today the US Food and Drug Administration FDA cleared its investigational new drug IND application for the drug candidate IMG a noncovalent reversible thirdgeneration Bruton Tyrosine Kinase BTK inhibitor to...
Neurocrine Biosciences Receives Orphan Drug Designation for Valbenazine as a Treatment for Chorea Associated with Huntington Disease
Friday, May 13, 2022Neurocrine Biosciences Inc announced that it has received Orphan Drug Designation from the US Food and Drug Administration FDA for valbenazine as a treatment for Huntington disease HD The treatment of chorea associated with HD is within the scope of...
Mindset Pharma Progresses Plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014
Friday, May 13, 2022Mindset Pharma Inc a drug discovery and development company focused on creating optimized and patentable nextgeneration psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs today announced that it is making h...
Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases
Thursday, May 12, 2022Nuvig Therapeutics Inc announced today the launch of the company to develop novel therapeutics that induce mechanisms of immune homeostasis and treat autoimmune diseases without compromising normal immune function To support this mission the company...
Neuvivo Begins Manufacturing of NP001 for Treatment of ALS
Thursday, May 12, 2022Neuvivo a biopharmaceutical company dedicated to delivering an effective safe ALS treatment to patients today announced that it has initiated cGMP manufacturing of NP for the treatment of ALS Lou Gehrigs Disease The company expects to have product a...
Pfizer to Acquire Biohaven Pharmaceuticals
Wednesday, May 11, 2022Pfizer Inc and Biohaven Pharmaceutical Holding Company Ltd announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven the maker of NURTEC ODT an innovative dualacting migraine therapy approved for b...
Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Biologics Development and Compliance
Wednesday, May 11, 2022Thermo Fisher Scientific today launched a new collection of qPCR biopharma offerings to help accelerate drug development to meet a growing demand for novel biologics The QualTrak comprehensive suite of qPCR tools is comprised of a premium selection o...
OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases
Tuesday, May 10, 2022OPKO Health Inc a multinational biopharmaceutical and diagnostics company today announced the acquisition of ModeX Therapeutics Inc a privately held biotechnology company focused on developing innovative multispecific immune therapies for cancer and...
Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine
Tuesday, May 10, 2022Hitachi HighTech Corporation has entered into a strategic partnership the Partnership with Invivoscribe Inc a global provider of blood cancer testing kits and services by undertaking a minority investmentbased thirdparty allotment of shares The Partn...
Citius Pharmaceuticals to Accelerate Phase 3 Mino-Lok Trial by Expanding Trial Sites Internationally
Monday, May 09, 2022Citius Pharmaceuticals Inc a latestage biopharmaceutical company developing and commercializing firstinclass critical care products today announced that it has selected Biorasi LLC Biorasi a global clinical research organization CRO to help expand th...
